Prosecution Insights
Last updated: October 04, 2026

Riverside Law LLP

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

176 pending office actions • 62 clients • 163 examiners • 83 art units • 0 of 176 (0%) have an AI response strategy ready

Analysis

Riverside Law LLP manages 4468 career applications in the Biotechnology & Pharmaceuticals technology area. The firm has a resolved allowance rate of 81.08 percent. It averages 4.12 office actions per allowance, which indicates a more prolonged prosecution process is typical for this firm.

Currently, the firm has 156 pending office actions. The 81.08 percent allowance rate is derived from the 4468 career applications. The 4.12 average office actions per allowance suggests that multiple rounds of examiner interaction are common to reach an allowance in the biotechnology field. This data reflects the firm's prosecution experience and strategy.

The 4468 career applications provide a substantial data set for evaluating the firm's 81.08 percent allowance rate. The 156 pending office actions show a significant current workload. Practitioners can use the average office actions per allowance to benchmark the expected effort and duration for new applications.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=4468 apps, methodology: how we score firms)

81.1%
Allowance Rate
n=4468
+0.69σ
Allowance Rate (norm)
n=4468
4.1
OAs to Allowance
n=1654
+0.04σ
OAs to Allow (norm)
n=1654
1173 days
Time to Allowance
n=1654
+17.4pp
Interview Lift
n=4468
41.1%
RCE Rate
n=4468
0.8%
Appeal Rate
n=4468

Rejection Performance (% of received rejections ultimately overcome)

65.8%
§101 Overcome
n=357
67.7%
§102 Overcome
n=1077
65.8%
§103 Overcome
n=1437
69.0%
§112 Overcome
n=1405

Specialization & Scale

A61K, A61P, C12N
Top CPC Subclasses
33%
Top-3 CPC Share
n=4468
8
Practitioners
n=4468
558.5
Apps / Practitioner
n=4468

Portfolio Summary

176
Total Pending OAs
96
Non-Final OAs
79
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 71 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

36
Overdue
4
Due this week
21
Due this month
8
Due in next 60 days
2
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 71 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (36)Due ≤ 7 days (4)Due ≤ 30 days (21)Due ≤ 60 days (8)Due later (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

104
Hard (59%)
54
Medium (31%)
18
Easy (10%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only3 (2%)
§101 + other23 (13%)
§103 only36 (20%)
§102 only4 (2%)
§112 only14 (8%)
Double-patenting only4 (2%)
Double-patenting + other14 (8%)
Multi-statute (no §101)78 (44%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

99
Life Sciences
56% of docket
1
Information Tech
1% of docket
1
Communications
1% of docket
4
Semiconductors
2% of docket
45
Mechanical / Eng
26% of docket
26
Business / Other
15% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

1,760 h
Manual time on pending OAs
352 h
Time saved (low, 20%)
616 h
Time saved (mid, 35%)
15.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
GRIZER, CASSANDRA SENN 2 75.0% +18.8%
WILSON, KAYLEE R 2 62.1% +53.4%
YOON, CHANEL J 2 55.0% +40.1%
ALLEN, MARIANNE P 2 60.1% +18.2%
LANNU, JOSHUA DARYL DEANON 2 82.1% +24.2%
SCHUBERG, LAURA J 2 23.6% +37.0%
ROSSI, JULIA ANNE LORRAIN 2 45.7% +61.3%
BAUSCH, SARAE L 2 29.8% +44.7%
VIVLEMORE, TRACY ANN 2 73.0% +6.6%
CHERNYSHEV, OLGA N 2 54.5% +34.4%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18322109 CONTOUR ELECTROCORTICOGRAPHY (ECoG) ARRAY LANNU, JOSHUA DARYL DEANON —

Hard Cases (105)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17907697 Synthetic Soluble Receptor Mimics and Methods of Use for Treatment of COVID-19 ROSSI, JULIA ANNE LORRAIN 167d overdue
18064482 LARGE AND SMALL T ANTIGENS OF MERKEL CELL POLYOMAVIRUS, NUCLEIC ACID CONSTRUCTS AND VACCINES MADE THEREFROM, AND METHODS OF USING SAME FOLEY, SHANON A 138d overdue
18458214 Recombinant Fusion Proteins Targeting P-selectin, and Methods of Use Thereof for Treating Diseases and Disorders ALLEN, MARIANNE P 104d overdue
18248166 METHOD FOR DETERMINING WHETHER OR NOT VIRUS-NEUTRALIZING ANTIBODIES ARE PRESENT AND IN VITRO METHOD FOR SCREENING COMPOUNDS FOR THEIR ABILITY TO NEUTRALIZE A VIRUS GRIZER, CASSANDRA SENN 84d overdue
18001116 CORONAVIRUS DISEASE 2019 (COVID-19) COMBINATION VACCINE ALLEN, MICHAEL D 79d overdue
17488409 DIGITALLY COACHED SPIROMETRY SYSTEM AND METHOD CATINA, MICHAEL ANTHONY 66d overdue
17425384 NOVEL BIOMARKERS AND DIAGNOSTIC PROFILES FOR PROSTATE CANCER CLOW, LORI A 66d overdue
19067406 Doped Organic Semiconductors and Methods of Making the Same NGUYEN, HAIDUNG D 45d overdue

Interview Candidates (18)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17907697 Synthetic Soluble Receptor Mimics and Methods of Use for Treatment of COVID-19 ROSSI, JULIA ANNE LORRAIN 167d overdue
18458214 Recombinant Fusion Proteins Targeting P-selectin, and Methods of Use Thereof for Treating Diseases and Disorders ALLEN, MARIANNE P 104d overdue
18248166 METHOD FOR DETERMINING WHETHER OR NOT VIRUS-NEUTRALIZING ANTIBODIES ARE PRESENT AND IN VITRO METHOD FOR SCREENING COMPOUNDS FOR THEIR ABILITY TO NEUTRALIZE A VIRUS GRIZER, CASSANDRA SENN 84d overdue
18006321 LIQUID CRYSTAL SCAFFOLDS AND USE THEREOF SCHUBERG, LAURA J 37d overdue
18194781 METHODS FOR ISOLATING AND CULTURING LIVING CELLS USING METHOD OF PERMEABILIZING CELL MEMBRANE SCHUBERG, LAURA J 13d
18002125 Containment, Treatment, and Removal of Aerosolized Viral Contamination LANNU, JOSHUA DARYL DEANON 20d
18856345 STABILIZED SPIKE PROTEIN AND METHOD OF USE THEREOF AS A CORONAVIRUS DISEASE 2019 (COVID-19) VACCINE GRIZER, CASSANDRA SENN —
18783229 AESTHETIC METHOD OF BIOLOGICAL STRUCTURE TREATMENT BY MAGNETIC FIELD WILSON, KAYLEE R —

Client Portfolio (62 clients)

Client (Assignee)Pending OAs
Yale University 21
Wistar Institute 13
NEW YORK UNIVERSITY 10
Temple University 10
UNIVERSITY OF ROCHESTER 8
THOMAS JEFFERSON UNIVERSITY 8
Arizona State University 8
University of California 7
University of Texas 6
Catholic University of Korea 5
3D Print Innovations 4
Btl Medical Solutions A.S. 4
ANIMUSCURE INC. 4
Medical University of South Carolina 4
University of Pennsylvania 3
BTL 3
Seoul National University 3
Myraina, LLC 2
Dragonfly Therapeutics 2
Btl Medical Development A.S. 2
Mayo Clinic 2
AEVUMED, INC. 2
INOVIO PHARMACEUTICALS, INC. 2
QUEEN MARY UNIVERSITY OF LONDON 2
PROGENEER INC. 2
DEUTSCHES ZENTRUM FÜR NEURODEGENERATIVE ERKRANKUNGEN E.V. 2
UEA ENTERPRISES LIMITED 2
Astero Biopharma LLC 1
NOVADATA SOLUTIONS LLC 1
MATSCITECHNO LICENSING COMPANY 1
Daniel Kulp 1
Chung-Ang University 1
New York University in Abu Dhabi Corporation 1
Colorado School of Mines 1
BPMED CO., LTD. 1
KOREA TRANSPORTATION SAFETY AUTHORITY 1
Flowerpod, LLC 1
Muonx, LLC 1
THE FRANCIS CRICK INSTITUTE LIMITED 1
Jasmine Li 1
Kyungpook National University 1
THE ROCKEFELLER UNIVERSITY 1
UNIVERSITAT DE BARCELONA 1
BIOGO CO., LTD. 1
University of Kansas 1
GenieUs Genomics Pty Ltd 1
EXIMMIUM BIOTECHNOLOGIES GMBH 1
Amir NASAJPOUR 1
AERAGEN, INC. 1
David WEINER 1
GOD'S OWN FOOD SOLUTIONS PVT LTD 1
Biotalys 1
Dow Inc. 1
Bkon LLC 1
U.S. Government 1
Asymchem 1
UE LifeSciences Inc. 1
Monitored Therapeutics 1
Roy Duncan 1
LMU Klinikum 1
The United States Government AS Represented By The Department Of Veterans Af 1
Medinno Inc. 1

Top Art Units

Art UnitApps
37919
37926
16725
16315
37004
16534
16454
16714
16374
16754

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19381766 Apparatus, Method, and System for Medical Imaging and Characterization of Tissue Structure UNIVERSITY OF ROCHESTER EDUN, DEAN NAWAAB 3797 §102§103§112 Non-Final OA — Pending Nov 06, 2025
19286887 APPROACHES FOR THE SELECTIVE DEPLETION OF PLA2R-SPECIFIC ANTIBODIES Astero Biopharma LLC DENT, ALANA HARRIS 1643 §101 Final Rejection — Pending Jul 31, 2025
19196969 DRYING EQUIPMENT USAGE AUDIT SYSTEM AND METHOD Novadata Solutions LLC JARRETT, SCOTT L §101§102 Non-Final OA — Pending May 02, 2025
19175271 INTRACAVITARY, PHYSIOLOGICAL AUGMENTATION DEVICE AND METHOD Yale University SAHAND, SANA §102§103§112 Non-Final OA — Pending Apr 10, 2025
19077565 INTRACARDIAC DEVICE Yale University MOSS, JAMES R §103§112DP Non-Final OA — Pending Mar 12, 2025
19067406 Doped Organic Semiconductors and Methods of Making the Same New York University NGUYEN, HAIDUNG D 1761 §102§103§112 Final Rejection 45d overdue Pending Feb 28, 2025
19014404 SYSTEM AND METHOD FOR ASSESSMENT AND REHABILITATION OF BALANCE IMPAIRMENT USING VIRTUAL REALITY Temple University-Of The Commonwealth System Of Higher Education OGLES, MATTHEW ERIC §103§112 Non-Final OA — Pending Jan 09, 2025
18985963 APPARATUS, SYSTEM AND METHOD FOR AN ADDITIVE MANUFACTURING PRINT HEAD 3D Print Innovations, LLC MCKANE, ELIZABETH L 3991 §103 Final Rejection 48d Pending Dec 18, 2024
18982230 SYSTEM AND METHOD FOR OPERATING SAFETY LIGHTING WHEN A FALL IS PREDICTED OR DETECTED Myraina, LLC PREVIL, DANIEL 2685 §103 Final Rejection — Pending Dec 16, 2024
18981897 SYSTEM AND METHOD FOR MODIFYING A LIVING ENVIRONMENT TO ASSIST IN FALL PREVENTION Myraina, LLC CHEN, PATRICK C 2842 §103§112 Non-Final OA — Pending Dec 16, 2024
18975545 Use of short chain fatty acids for the treatment and prevention of diseases and disorders Temple University-Of The Commonwealth System Of Higher Education ALLEY, GENEVIEVE S §103DP Non-Final OA — Pending Dec 10, 2024
18971619 APPARATUS, SYSTEM AND METHOD OF PROVIDING A FFF PRINTING NOZZLE 3D Print Innovations, LLC TSUI, YUNG-SHENG M 1743 §102§112 Final Rejection — Pending Dec 06, 2024
18966538 ARAMID REINFORCED INSTANT FLEXIBLE CAST STRIPS Matscitechno Licensing Company FISHER, VICTORIA HICKS 3786 §103 Final Rejection — Pending Dec 03, 2024
18868003 DEVICE AND METHOD FOR TREATMENT OF PART OF A HUMAN BODY Btl Medical Solutions A.S. FOWLER, DANIEL WAYNE 3794 §102§103§112 Non-Final OA — Pending Nov 21, 2024
18940457 SYSTEM AND METHOD FOR ASSESSING INTRACRANIAL ANEURYSMS New York University NEWTON, CHAD A 3681 §101§103 Final Rejection — Pending Nov 07, 2024
18939015 SYSTEM AND METHOD FOR TETHERED UNMANNED AERIAL VEHICLE TAKEOFF, LANDING, AND STORAGE Dragonfly Pictures, Inc. BAAJOUR, SHAHIRA 3666 §103 Non-Final OA 41d Pending Nov 06, 2024
18939033 SYSTEM AND METHOD FOR TETHERED UNMANNED AERIAL VEHICLE TAKEOFF, LANDING, AND STORAGE Dragonfly Pictures, Inc. MCFALL, NICHOLAS A 3644 §102§103§112 Non-Final OA — Pending Nov 06, 2024
18856984 DEVICE, SYSTEM, AND METHOD FOR TISSUE IDENTIFICATION DURING ROBOTIC SURGERY The Regents of the University of California SCHERBEL, TODD J 3792 §102§112 Non-Final OA — Pending Oct 15, 2024
18856345 STABILIZED SPIKE PROTEIN AND METHOD OF USE THEREOF AS A CORONAVIRUS DISEASE 2019 (COVID-19) VACCINE Daniel Kulp GRIZER, CASSANDRA SENN §112 Non-Final OA — Pending Oct 11, 2024
18904575 Compositions and Methods for Targeting Lipid Nanoparticle Therapeutics to Stem Cells The Trustees of the University of Pennsylvania WESTERBERG, NISSA M 1618 §103DP Final Rejection 18d overdue Pending Oct 02, 2024
18852059 COMPACT SCALABLE DISSOLVED OXYGEN SENSOR Yale University TRAN, VIVIAN AILINH 1794 §103§112 Non-Final OA — Pending Sep 27, 2024
18848241 DEVICES AND METHODS FOR RAPID BIOSENSING New York University SANGHERA, JAS A 2852 §102§103§112 Non-Final OA — Pending Sep 18, 2024
18820570 PULSED FIELD ABLATION DEVICE AND METHOD Btl Medical Development A.S. PEFFLEY, MICHAEL F §102§103 Non-Final OA — Pending Aug 30, 2024
18815038 Discrete Microenvironment Chamber New York University HUANG, MICKEY NMN 1758 §102§103 Final Rejection — Pending Aug 26, 2024
18814421 SWITCHING OF PERPENDICULARLY MAGNETIZED NANOMAGNETS WITH SPIN-ORBIT TORQUES IN THE ABSENCE OF EXTERNAL MAGNETIC FIELDS UNIVERSITY OF ROCHESTER NGUYEN, VAN THU T 2824 §102§103 Final Rejection 15d Pending Aug 23, 2024
18793238 METHODS AND COMPOSITIONS FOR TREATING LIVER DISEASE Temple University-Of The Commonwealth System Of Higher Education ROBINSON, MIKHAIL O'DONNEL §102§103 Non-Final OA — Pending Aug 02, 2024
18784215 DEVICE, SYSTEM, AND METHOD FOR NEUROMODULATION Mayo Foundation for Medical Education and Research PRUITT, HALEY NICOLE 3796 §103 Non-Final OA — Pending Jul 25, 2024
18783229 AESTHETIC METHOD OF BIOLOGICAL STRUCTURE TREATMENT BY MAGNETIC FIELD Btl Medical Solutions A.S. WILSON, KAYLEE R 3700 §103§112Other Non-Final OA — Pending Jul 24, 2024
18728224 Quantized Bistable Resistively-coupled Ising Machine UNIVERSITY OF ROCHESTER KINKEAD, ARNOLD M 2849 §102Other Non-Final OA — Pending Jul 11, 2024
18745131 SYSTEM AND METHOD FOR BREAST CANCER DETECTION USING CO-LOCALIZED ULTRASOUND-MAMMOGRAPHY Thomas Jefferson University FERNANDEZ, KATHERINE L 3798 §103§112 Final Rejection 14d Pending Jun 17, 2024
18740678 Method and device for microwave treatment Btl Healthcare Technologies A.S. SHOULDERS, ANNIE LEE 3794 §102§103 Non-Final OA — Pending Jun 12, 2024
18712889 METHOD FOR PRODUCING CULTURED MEAT BY UTILIZING FBS SUBSTITUTE DERIVED FROM BUTCHERY BY-PRODUCTS Chung-Ang University Industry-Academic Cooperation Foundation REGLAS, GILLIAN CHELSEA §103§112 Non-Final OA — Pending May 23, 2024
18659711 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING COLON CANCER INCLUDING EXTRACELLULAR VESICLES LOADED WITH MACC1 INHIBITOR AS ACTIVE INGREDIENT The Catholic University Of Korea Industry-Academic Cooperation Foundation TATGE, LEXUS MARC §112 Non-Final OA — Pending May 09, 2024
18658276 EXTRAMAMMARY PAGET DISEASE BIOMARKERS AND USES THEREOF The Catholic University Of Korea Industry-Academic Cooperation Foundation BOWERS, ERIN M 1653 §101§103§112 Non-Final OA — Pending May 08, 2024
18707382 DRUG ELUTING NERVE GUIDE CONDUIT New York University In Abu Dhabi Corporation KHANDKER, RAIHAN R 3771 §102§103 Final Rejection — Pending May 03, 2024
18650511 Reverse Osmosis Systems and Methods Colorado School Of Mines ORME, PATRICK JAMES §102§103§112 Non-Final OA — Pending Apr 30, 2024
18647191 METHOD FOR PRODUCING VASCULARIZED RESPIRATORY ORGANOID FUSED WITH BLOOD VESSEL ORGANOID The Catholic University Of Korea Industry-Academic Cooperation Foundation WILSON, MICHAEL C §103§112 Non-Final OA — Pending Apr 26, 2024
18705288 NOROVIRUS VACCINE AND METHODS OF USE The Trustees of the University of Pennsylvania CHONG, KIMBERLY §102§103§112 Non-Final OA — Pending Apr 26, 2024
18704129 COMPOSITION COMPRISING BOTULINUM-DERIVED PEPTIDE FOR PAIN RELIEF BPMED CO., LTD. GOUGH, TIFFANY MAUREEN 1651 §102 Non-Final OA — Pending Apr 24, 2024
18640327 PREDICTIVE MAINTENANCE ALGORITHM PROVIDING METHOD FOR BUS MAINTENANCE PRIORITY DETERMINATION Korea Transportation Safety Authority CLARE, MARK C 3628 §101 Non-Final OA — Pending Apr 19, 2024
18701320 METHODS AND SYSTEMS FOR PROCESSING AND FORMULATING PLANT MATERIAL Flowerpod, LLC PACKARD, BENJAMIN J 1612 §102§103§112 Non-Final OA 42d Pending Apr 15, 2024
18699081 Novel Immune Cell Engagers For Immunotherapy The Wistar Institute GURLEY, JAMI MICHELLE §102§103§112 Non-Final OA — Pending Apr 05, 2024
18628195 AUTOMATED OPTICAL MICROPIPETTE ELECTRODE GUIDANCE SYSTEM AND METHOD Arizona Board of Regents XU, XIAOYUN §103§112 Non-Final OA — Pending Apr 05, 2024
18690480 SYSTEM AND METHOD FOR STEREOSCOPIC IMAGE GENERATION New York University BRUTUS, JOEL F 3797 §103 Final Rejection 8d overdue Pending Mar 08, 2024
18593283 ANGLE-ADJUSTABLE RATCHET TOOL Thomas Jefferson University CHUKWURAH, NATHANIEL C 3723 §103 Non-Final OA — Pending Mar 01, 2024
18588643 MAGE-A VACCINES AND METHODS OF TREATMENT USING THE SAME The Wistar Institute EDGINGTONGIORDANO, FRANCESCA 1643 §101§102§112Other Non-Final OA 37d overdue Pending Feb 27, 2024
18443564 DEVICE AND METHOD FOR ENGAGING A ZIPPER Thomas Jefferson University MELIKA, ERMIA EMAD §102§103§112 Non-Final OA — Pending Feb 16, 2024
18439561 SYSTEMS AND METHODS FOR TISSUE TREATMENT Btl Healthcare Technologies A.S. SISON, CHRISTINE ANDREA PAN 3792 §103DP Non-Final OA 2d overdue Pending Feb 12, 2024
18681192 LEPTOSPIRAL VIRULENCE MODULATING PROTEINS AND USES THEREOF Yale University DUFFY, PATRICIA ANN 1645 §101§102§112 Non-Final OA — Pending Feb 05, 2024
18431444 ROLLINGCACHE: USING RUNTIME BEHAVIOR TO DEFEND AGAINST CACHE SIDE CHANNEL ATTACKS UNIVERSITY OF ROCHESTER LIU, ZHE 2493 §103§112 Non-Final OA — Pending Feb 02, 2024
18426838 Microencapsulation of Active Agents Temple University-Of The Commonwealth System Of Higher Education CABRAL, ROBERT S §102§103 Non-Final OA — Pending Jan 30, 2024
18291968 Methods and Apparatuses for Wearable Neuromodulation Pain Relief Device Muonx, LLC KOHUTKA, BROOKE NICOLE §101§102§103§112 Non-Final OA — Pending Jan 25, 2024
18413255 FUNCTIONALIZED N,N-DIALKYLAMINO PHENYL ETHERS AND THEIR METHOD OF USE Temple University-Of The Commonwealth System Of Higher Education HAVLIN, ROBERT H 1626 §102§112DP Non-Final OA — Pending Jan 16, 2024
18576830 VCP INHIBITORS AND USES THEREOF FOR TREATMENT The Francis Crick Institute Limited CHONG, YONG SOO 1623 §102§103§112 Non-Final OA — Pending Jan 05, 2024
18571863 FUNCTIONAL MASK Jasmine Li DIXON, ANNETTE FREDRICKA §102§103§112 Final Rejection — Pending Dec 19, 2023
18545834 AESTHETIC METHOD OF BIOLOGICAL STRUCTURE TREATMENT BY MAGNETIC FIELD Btl Medical Solutions A.S. WILSON, KAYLEE R 3700 §102§103§112Other Non-Final OA — Pending Dec 19, 2023
18569842 MORPHABLE BONE FIXATION DEVICE, SYSTEM AND METHOD BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM JOHANAS, JACQUELINE T 3773 §102§103§112 Final Rejection 22d Pending Dec 13, 2023
18566362 DRUG-ELUTING TUBES FOR IMPROVED PATIENT CARE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM WRUBLESKI, MATTHEW JAMES 3781 §103 Final Rejection 23d Pending Dec 01, 2023
18565862 PREPARATION AND STANDARDIZATION OF CELL SPHEROIDS FOR PROMOTING TISSUE REGENERATION Seoul National University Hospital BARRON, SEAN C 1653 §103 Final Rejection — Pending Nov 30, 2023
18515486 COMPOSITION FOR INHIBITING SKIN PIGMENTATION THROUGH AUTOPHAGY ACTIVITY CONTAINING PROCYANIDIN A2 AND QUERCETIN, AS ACTIVE INGREDIENTS Kyungpook National University Industry-Academic Cooperation Foundation MAYHEW, BRADLEY SCOTT 1621 §102§103 Non-Final OA — Pending Nov 21, 2023
18562564 COMPOSITION COMPRISING INOTODIOL FOR PREVENTION OR TREATMENT OF MUSCULAR DISEASE Animuscure Inc. BAUER, NICOLA MARIA 1621 §103 Non-Final OA — Pending Nov 20, 2023
18512161 PULSED FIELD ABLATION DEVICE AND METHOD Btl Medical Development A. S. ZINK, AMANDA L 3794 DP Non-Final OA — Pending Nov 17, 2023
18512727 3D PRINTED SCAFFOLDS FOR USE IN TISSUE REPAIR Aevumed, Inc. STRANSKY, KATRINA MARIE 3700 §102§103 Final Rejection 2d overdue Pending Nov 17, 2023
18508879 Smart Wearable IOT Device for Health Tracking, Contact Tracing and Prediction of Health Deterioration New York University HUSSAINI, ATTIYA SAYYADA 3792 §102§103§112 Non-Final OA — Pending Nov 14, 2023
18503487 Vaccines For Human Papilloma Virus And Methods For Using The Same Inovio Pharmaceuticals, Inc. ZOU, NIANXIANG 1671 DP Non-Final OA 138d overdue Pending Nov 07, 2023
18558013 Lipid Nanoparticle Therapeutics that Evade the Immune Response The Trustees of the University of Pennsylvania HOWARD, ZACHARY C 1674 §102§112 Non-Final OA — Pending Oct 30, 2023
18557729 COMPOSITION FOR PREVENTING OR TREATING MUSCULAR DISEASE, COMPRISING OXICAM-BASED COMPOUND Animuscure Inc. NEAGU, IRINA 1629 §102§103§112 Non-Final OA — Pending Oct 27, 2023
18557654 MACOLACINS AND METHODS OF USE THEREOF The Rockefeller University VARADARAJ, ARCHANA 1653 §101§102§103 Non-Final OA — Pending Oct 27, 2023
18494330 SYSTEM AND METHOD FOR LEARNING SPARSE FEATURES FOR SELF-SUPERVISED LEARNING WITH CONTRASTIVE DUAL GATING Arizona Board of Regents CHAN, HOWIE 4100 §101§103 Non-Final OA — Pending Oct 25, 2023
18556414 GLYCAN MODIFIED SPIKE RECEPTOR BINDING DOMAIN NANOPARTICLES AND METHOD OF USE THEREOF AS A CORONAVIRUS DISEASE 2019 (COVID-19) VACCINE The Wistar Institute BOESEN, AGNIESZKA 1672 §102§112DP Non-Final OA 84d Pending Oct 20, 2023
18486265 DEVICE, SYSTEM AND METHOD FOR CONTINUOUS ESTIMATION OF ORGAN AND TISSUE SIZE AND CONTENT WITHIN AN INTACT ORGANISM Yale University YOON, CHANEL J 3791 §103§112 Non-Final OA — Pending Oct 13, 2023
18555112 COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CANCER Yale University COUGHLIN, MATTHEW P 1626 §102§103 Final Rejection 13d Pending Oct 12, 2023
18553437 ANGIOGENESIS INHIBITING PEPTIDE AND USE THEREOF Seoul National University Hospital COFFA, SERGIO 1658 §102§112DP Non-Final OA — Pending Sep 29, 2023
18469813 PROCESSES FOR PREDICTING THERAPY BENEFITS The Wistar Institute STUBBS, JOHN THOMAS §101§103§112 Non-Final OA — Pending Sep 19, 2023
18467202 SYSTEM AND METHOD FOR AUTONOMOUS CHARGING New York University OMAR, AHMED H §102§103 Non-Final OA — Pending Sep 14, 2023
18465301 Cellular Analysis with Topology and Condensation Homology (CATCH) Analysis and Method of Use Yale University TOKARCZYK, CHRISTOPHER B 3687 §102§103§112 Non-Final OA — Pending Sep 12, 2023
18464568 APPARATUS, SYSTEM AND METHOD OF ADDITIVE MANUFACTURING USING ULTRA-FINE JETTED MATERIAL 3D Print Innovations, LLC YE, XINWEN 1754 §103§112 Final Rejection — Pending Sep 11, 2023
18458214 Recombinant Fusion Proteins Targeting P-selectin, and Methods of Use Thereof for Treating Diseases and Disorders UNIVERSITAT DE BARCELONA ALLEN, MARIANNE P 1647 §102§103§112Other Non-Final OA 104d overdue Pending Aug 30, 2023
18455834 MOTION-ACTIVATED, CLOSED-LOOP NON-INVASIVE VAGUS NERVE STIMULATION FOR NEUROREHABILITATION Musc Foundation For Research Development EDWARDS, PHILIP CHARLES 3792 §103 Final Rejection — Pending Aug 25, 2023
18450169 APPARATUS, SYSTEM AND METHOD FOR ULTRASONIC-BASED ADDITIVE MANUFACTURING 3D Print Innovations LLC HEMINGWAY, TIMOTHY G 1754 §103§112 Non-Final OA 4d overdue Pending Aug 15, 2023
18264701 RENAL NEUROMODULATION The Regents of the University of California TEJANI, ANKIT D 3796 §103Other Non-Final OA 19d overdue Pending Aug 08, 2023
18360140 SYSTEM AND METHOD FOR NEURAL NETWORK MULTIPLE TASK ADAPTATION Arizona Board of Regents WASAFF, JOHN S. 3629 §103 Final Rejection — Pending Jul 27, 2023
18359521 EXOSUIT DEVICE AND METHOD FOR EXOSUIT MODELING AND DESIGN BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM MILLER, DANIEL A 3786 §103§112 Final Rejection 5d Pending Jul 26, 2023
18261568 Staphylococcus aureus Antigen-Based Nucleic Acid Vaccines UNIVERSITY OF ROCHESTER GRASER, JENNIFER E 1645 §103§112 Final Rejection 5d Pending Jul 14, 2023
18342930 LUNG CANCER MODELING USING NORMAL LUNG ORGANOID WITH LUNG CANCER CELLS The Catholic University Of Korea Industry-Academic Cooperation Foundation CANDELARIA, JULIANA IRENE 1634 §103§112 Final Rejection 14d Pending Jun 28, 2023
18257609 WEARABLE INERTIAL SENSOR SYSTEM AND METHODS New York University YOON, CHANEL J 3791 §101§103§112 Non-Final OA — Pending Jun 15, 2023
18256752 SUSTAINED RELEASE FORMULATIONS OF CRYSTALLINE DRUGS Queen Mary University Of London KASSA, TIGABU 1619 §103 Final Rejection 8d overdue Pending Jun 09, 2023
18329957 METHODS OF TREATING DISEASES AND DISORDERS ASSOCIATED WITH CALCIUM ION SIGNALING Temple University-Of The Commonwealth System Of Higher Education SZNAIDMAN, MARCOS L 1628 §103§112 Final Rejection 9d overdue Pending Jun 06, 2023
18254052 COMPOSITION FOR PREPARING DECELLULARIZED SCAFFOLD, COMPRISING GRAPHENE NANOSTRUCTURE BIOGO CO., LTD. WOZNICKI, JACQUELINE 3774 §103§112 Final Rejection 16d Pending May 23, 2023
18254027 TRNA FRAGMENTS AND METHODS OF USE Thomas Jefferson University YU, DELPHINUS DOU YI 1636 §101§102§112 Non-Final OA — Pending May 23, 2023
18322109 CONTOUR ELECTROCORTICOGRAPHY (ECoG) ARRAY Mayo Foundation for Medical Education and Research LANNU, JOSHUA DARYL DEANON 3792 §103 Final Rejection — Pending May 23, 2023
18253520 ALGORITHMS FOR PREDICTING VUG CONNECTIVITY UNIVERSITY OF KANSAS KIM, EUNHEE §102§103§112 Non-Final OA — Pending May 18, 2023
18253250 TARGETING HOST-BACTERIA INTERACTIONS FOR THE TREATMENT OF MICROBIOTA-MEDIATED DISEASES Yale University GROSS, CHRISTOPHER M 1684 §102§112 Non-Final OA — Pending May 17, 2023
18252440 FLOW REGULATION MECHANISM FOR COMPARTMENTALIZED LUNG VENTILATION The Regents of the University of California RUSSELL, SYDNEY REYES 3785 §103§112 Final Rejection 3d overdue Pending May 10, 2023
18312793 SYSTEM AND METHOD FOR REMOVING CARBON DIOXIDE FROM SEA WATER Yale University KEYWORTH, PETER 1777 §112 Non-Final OA — Pending May 05, 2023
18034693 DEVICES AND METHODS FOR MONITORING CELLS, TISSUES, OR ORGANS-ON-A-CHIP UNIVERSITY OF ROCHESTER GERHARD, ALISON CLAIRE 1797 §103 Non-Final OA 19d Pending Apr 29, 2023
18250629 COMPOSITION FOR PREVENTION OR TREATMENT OF NEUROMUSCULAR DISEASES COMPRISING CDO PROTEIN OR GENE ENCODING SAME Animuscure Inc. VYAS, KEYUR ANILKUMAR 1637 §103§112 Final Rejection 6d Pending Apr 26, 2023
18250117 DETECTION OF DELETIONS IN OLIGONUCLEOTIDE SEQUENCES Genieus Genomics Pty Ltd. MINCHELLA, KAITLYN L §101§112 Non-Final OA — Pending Apr 21, 2023
18134886 NANOSCALE PROCESS TO GENERATE REAGENTS SELECTIVE FOR INDIVIDUAL PROTEIN VARIANTS Arizona Board of Regents DRISCOLL, LORA E BARNHART 3991 §112Other Non-Final OA — Pending Apr 14, 2023
18248648 COMPOSITION FOR PREVENTING OR TREATING NEUROMUSCULAR DISEASE, COMPRISING PRMT1 PROTEIN OR GENE ENCODING SAME Animuscure Inc. DAVIS, RUTH A 1699 §103§112 Final Rejection 70d Pending Apr 11, 2023
18297160 NASAL MOLDING DEVICE New York University JAMIALAHMADI, MAJID 3771 §103§112 Non-Final OA 26d overdue Pending Apr 07, 2023
18248166 METHOD FOR DETERMINING WHETHER OR NOT VIRUS-NEUTRALIZING ANTIBODIES ARE PRESENT AND IN VITRO METHOD FOR SCREENING COMPOUNDS FOR THEIR ABILITY TO NEUTRALIZE A VIRUS Eximmium Biotechnologies GmbH GRIZER, CASSANDRA SENN 1672 §101§102§103§112 Final Rejection 84d overdue Pending Apr 06, 2023
18194781 METHODS FOR ISOLATING AND CULTURING LIVING CELLS USING METHOD OF PERMEABILIZING CELL MEMBRANE Seoul National University Hospital SCHUBERG, LAURA J 1631 §103 Final Rejection 13d Pending Apr 03, 2023
18247519 Advanced Cell-Permeable Peptide Carriers Musc Foundation For Research Development PAULUS, ERIN VIRGINIA 1631 §103 Final Rejection 29d overdue Pending Mar 31, 2023
18191314 MONITORING NEUROLOGICAL FUNCTIONAL STATUS Musc Foundation For Research Development NGUYEN, HUONG Q 3791 §103 Non-Final OA 29d overdue Pending Mar 28, 2023
18190466 DEVICE FOR REPETITIVE NERVE STIMULATION IN ORDER TO BREAK DOWN FAT TISSUE MEANS OF INDUCTIVE MAGNETIC FIELDS Btl Medical Solutions A.S. MATTHEWS, CHRISTINE HOPKINS 3791 §101§103§112 Non-Final OA — Pending Mar 27, 2023
18041123 METABOLISM-BASED CHIMERIC ANTIGEN RECEPTORS AND METHODS OF TREATMENT Arizona Board of Regents DEBERRY, REGINA M 1647 §102§103§112 Non-Final OA — Pending Feb 09, 2023
18040515 METHODS AND COMPOSITIONS FOR TREATING CYTOKINE RELEASE SYNDROME Temple University-Of The Commonwealth System Of Higher Education PIHONAK, SARAH 1627 §103§112 Final Rejection 45d overdue Pending Feb 03, 2023
18040484 POLYMERIC COMPOSITE MEMBRANES HAVING ORIENTED NANOCHANNELS AND METHODS OF MAKING THE SAME Yale University MCCULLOUGH, ERIC J. 1773 §103 Final Rejection — Pending Feb 03, 2023
18040318 MRNA VACCINE COMPRISING ADJUVANT CAPABLE OF KINETIC CONTROL Progeneer Inc. ALLEN, SARAH ELIZABETH 1637 §103§112DP Final Rejection — Pending Feb 02, 2023
18040328 KINETICALLY ACTING ADJUVANT ENSEMBLE Progeneer Inc. ROSSI, JULIA ANNE LORRAIN 1615 §103§112 Non-Final OA — Pending Feb 02, 2023
18006590 RAPID CLINICAL TEST FOR GENETIC DIAGNOSIS INVOLVING KNOWN VARIANTS Yale University BAUSCH, SARAE L 1699 §102§103 Non-Final OA — Pending Jan 24, 2023
18006321 LIQUID CRYSTAL SCAFFOLDS AND USE THEREOF Amir Nasajpour SCHUBERG, LAURA J 1631 §102§103 Final Rejection 37d overdue Pending Jan 20, 2023
18005444 COMPOSITIONS AND METHODS RELATING TO TYPHOID TOXIN SUBUNIT PLTC Yale University DEVI, SARVAMANGALA 1645 §103 Final Rejection 4d overdue Pending Jan 13, 2023
18005311 Targeted RNA cleavage with dCas13-RNase Fusion Proteins UNIVERSITY OF ROCHESTER RYAN, DOUGLAS CHARLES 1635 §101§102§103§112 Final Rejection 27d Pending Jan 12, 2023
18004964 DNA ANTIBODY CONSTRUCTS FOR USE AGAINST ROTAVIRUS The Wistar Institute BUCKMASTER, MARLENE VRENI 1672 §102§103§112 Final Rejection — Pending Jan 10, 2023
18002995 System and Method for Detection of Biomolecules in Tissues, Organs, and Extracellular Fluid The Regents of the University of California JANG, CHRISTIAN Y 3791 §102§103 Final Rejection — Pending Dec 22, 2022
18002125 Containment, Treatment, and Removal of Aerosolized Viral Contamination Aeragen, Inc. LANNU, JOSHUA DARYL DEANON 3791 §103§112 Final Rejection 20d Pending Dec 16, 2022
18065736 MEASURING FREQUENCY OF PATHOGEN-SPECIFIC T CELLS IN PERIPHERAL BLOOD Thomas Jefferson University GAO, ASHLEY HARTMAN 1678 §103§112Other Final Rejection 22d Pending Dec 14, 2022
18064482 LARGE AND SMALL T ANTIGENS OF MERKEL CELL POLYOMAVIRUS, NUCLEIC ACID CONSTRUCTS AND VACCINES MADE THEREFROM, AND METHODS OF USING SAME The Wistar Institute FOLEY, SHANON A 1671 §102§112Other Non-Final OA 138d overdue Pending Dec 12, 2022
18001116 CORONAVIRUS DISEASE 2019 (COVID-19) COMBINATION VACCINE The Wistar Institute ALLEN, MICHAEL D 1671 §103§112Other Final Rejection 79d overdue Pending Dec 08, 2022
18000531 Monoclonal Antibody Against Human Siglec-9 and Use For Immunotherapy David Weiner JUEDES, AMY E 1644 §112Other Final Rejection 88d overdue Pending Dec 02, 2022
18061272 REGULARIZED DEEP LEARNING BASED IMPROVEMENT OF BIOMOLECULES Yale University MOHANTA, PRAMOD KUMAR 1686 §101§103§112 Non-Final OA — Pending Dec 02, 2022
18059196 SYSTEM AND METHODS FOR INCREASING SYNTHESIZED PROTEIN STABILITY BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM LUO, JAMMY NMN 1686 §101§103§112 Non-Final OA — Pending Nov 28, 2022
18059180 SYSTEM AND METHODS FOR INCREASING SYNTHESIZED PROTEIN STABILITY BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM ALLEN, MARIANNE P 1672 §102§103§112Other Non-Final OA — Pending Nov 28, 2022
18058366 MINIMALLY INVASIVE ANCHOR DRILL SYSTEMS Aevumed, Inc. DORNBUSCH, DIANNE 3771 §103 Final Rejection 32d overdue Pending Nov 23, 2022
17997963 DNA ANTIBODY CONSTRUCTS FOR USE AGAINST HEPATITIS B VIRUS The Wistar Institute XIAO, YAN 1642 §112 Final Rejection 28d Pending Nov 04, 2022
17997572 Epiprinter Technology and Methods of Use for Detecting Biomolecules Temple University-Of The Commonwealth System Of Higher Education BAUSCH, SARAE L 1699 §101§102§103§112 Final Rejection — Pending Oct 31, 2022
18046705 JACKFRUIT FLOUR, METHOD OF PREPARATION AND USES THEREOF God's Own Food Solutions Pvt. Ltd. MORENO, LARK JULIA 1793 §103 Final Rejection 8d Pending Oct 14, 2022
18045575 TERT IMMUNOGENIC COMPOSITIONS AND METHODS OF TREATMENT USING THE SAME Inovio Pharmaceuticals, Inc. ALAWADI, SARAH 1619 §102Other Final Rejection 34d Pending Oct 11, 2022
17907697 Synthetic Soluble Receptor Mimics and Methods of Use for Treatment of COVID-19 The Wistar Institute ROSSI, JULIA ANNE LORRAIN 1615 §102§103§112 Non-Final OA 167d overdue Pending Sep 29, 2022
17907703 ANTI-FUNGAL POLYPEPTIDES BIOTALYS NV SHARMA, SANTOSH 1663 §102§112DPOther Non-Final OA — Pending Sep 29, 2022
17906694 Preparation of Cerium (III) Carbonate Dispersion Rohm And Haas Company QUIST, NICOLE LEE 1738 §102§103 Final Rejection 23d overdue Pending Sep 19, 2022
17904229 LINKING AMINO ACID SEQUENCES, MANUFACTURING METHOD THEREOF, AND USE THEREOF Temple University-Of The Commonwealth System Of Higher Education MARVICH, MARIA 1634 §103 Non-Final OA — Pending Aug 15, 2022
17759649 CD40-L BLOCKADE TO ENHANCE SYNTHETIC ANTIBODY THERAPY The Wistar Institute BUNNER, BRIDGET E 1647 §102 Non-Final OA — Pending Jul 28, 2022
17813717 VACUUM INFUSION MACHINE AND VACUUM INFUSION METHOD Bkon LLC AXTELL, ASHLEY 1792 §103§112 Non-Final OA — Pending Jul 20, 2022
17813395 INTEGRATED CIRCUIT WITH TOPOLOGICAL SEMIMETAL INTERCONNECTS Yale University DUMBRIS, SETH M 1784 §103 Final Rejection 34d Pending Jul 19, 2022
17787729 VACCINES AGAINST AFRICAN SWINE FEVER VIRUS, AND METHODS OF USING SAME The Wistar Institute SIFFORD, JEFFREY MARK 1671 §101§102§103§112DP Non-Final OA — Pending Jun 21, 2022
17842225 METHODS FOR TREATING EYE DISEASE The United States Department of Veterans Affairs VIVLEMORE, TRACY ANN 1638 §103 Final Rejection 28d overdue Pending Jun 16, 2022
17782338 A T cell-based immunotherapy for central nervous system viral infections and tumors Yale University ALSOMAIRY, SARAH ABDOALATIF 1646 §103DP Final Rejection 15d Pending Jun 03, 2022
17772660 Continuous synthesis method for ethoxymethylenemalononitrile Asymchem Laboratories (Tianjin) Co., Ltd. CHENG, KAREN 1623 §103 Non-Final OA — Pending Apr 28, 2022
17640119 HERV INHIBITORS FOR USE IN TREATING TAUOPATHIES DEUTSCHES ZENTRUM FÜR NEURODEGENERATIVE ERKRANKUNGEN E.V. CHERNYSHEV, OLGA N 1675 §112 Final Rejection — Pending Mar 03, 2022
17637100 PORTABLE AND COMPACT SYSTEM FOR DELIVERY OF HUMIDIFIED HIGH FLOW NASAL CANNULA (HHFNC) THERAPY IN NEONATES AND INFANTS Yale University KHONG, BRIAN THAI-BINH 3700 §112 Final Rejection — Pending Feb 22, 2022
17636209 Metabolic Reprogramming of Immune Cells for the Treatment or Prevention of Diseases and Disorders Arizona Board of Regents NGUYEN, JOHN P 1619 §103Other Non-Final OA 19d overdue Pending Feb 17, 2022
17628951 METHODS FOR DIAGNOSING CANCER Queen Mary University Of London VANN-OJUEKAIYE, KENDRA RAYCHELL 1682 §101§103§112 Non-Final OA — Pending Jan 21, 2022
17628913 Targeted RNA cleavage with CRISPR-Cas UNIVERSITY OF ROCHESTER SPENCER, ANDREA LYNNE MORRIS 1631 §102§103§112 Final Rejection 20d Pending Jan 21, 2022
17627927 Inhibitors of microRNA 451a for Treatment of Endometriosis Yale University VIVLEMORE, TRACY ANN 1638 §103§112 Non-Final OA — Pending Jan 18, 2022
17627612 SYSTEM AND METHOD FOR MEASURING TISSUE PARAMETERS BY USE OF CAPACITIVE TACTILE SENSOR UE LifeSciences Inc. XU, JUSTIN 3791 §103 Final Rejection 14d Pending Jan 14, 2022
17626903 Genetically Modified Non-Human Animals and Methods of Use Thereof Yale University SINGH, ANOOP KUMAR 1632 §103§112 Non-Final OA — Pending Jan 13, 2022
17618390 OSTEOINDUCTIVE MODIFIED GELATIN HYDROGELS AND METHODS OF MAKING AND USING THE SAME The Regents of the University of California ALAM, AYAAN A 1611 §103§112 Non-Final OA — Pending Dec 10, 2021
17541154 NON-INVASIVE PROPRIOCEPTIVE STIMULATION FOR TREATING EPILEPSY The Regents of the University of California MILLER, CHRISTOPHER E 3785 §103 Non-Final OA 38d overdue Pending Dec 02, 2021
17611758 Metabolite Delivery for Modulating Metabolic Pathways of Cells Arizona Board of Regents PUTTLITZ, KARL J 1646 §103 Final Rejection — Pending Nov 16, 2021
17518243 DEVICE AND METHOD FOR UNATTENDED TREATMENT OF A PATIENT Btl Healthcare Technologies A.S. VOORHEES, CATHERINE M 3792 §103DP Final Rejection 71d overdue Pending Nov 03, 2021
17499777 METHODS FOR DETECTING TRAUMATIC BRAIN INJURY Arizona Board of Regents BALLARD, KIMBERLY 1675 §112 Non-Final OA — Pending Oct 12, 2021
17488409 DIGITALLY COACHED SPIROMETRY SYSTEM AND METHOD Monitored Therapeutics Inc. CATINA, MICHAEL ANTHONY 3791 §101§103 Final Rejection 66d overdue Pending Sep 29, 2021
17599023 METHODS FOR TREATING CANCERS USING ANTISENSE Thomas Jefferson University PERSONS, JENNA L 1637 §103§112DP Final Rejection — Pending Sep 28, 2021
17486823 ONCOLYTIC MYXOMA VIRUS EXPRESSING FAST P14 TO TREAT HEMATOLOGICAL CANCER Roy Duncan JADHAO, SAMADHAN JAISING 1672 §103Other Non-Final OA 38d overdue Pending Sep 27, 2021
15733794 NONWOVEN HEMP HURD-BASED MATERIALS Thomas Jefferson University SINGH-PANDEY, ARTI R 1759 DP Final Rejection 50d overdue Pending Sep 23, 2021
17431813 BEE GUT MICROBIAL FORMULATION FOR USE AS A PROBIOTIC FOR IMPROVED BEE HEALTH AND PATHOGEN RESISTANCE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM EIX, EMILY FAY 1653 §103§112 Non-Final OA 12d Pending Aug 18, 2021
17427434 DNA-ENCODED BISPECIFIC T-CELL ENGAGERS TARGETING CANCER ANTIGENS AND METHODS OF USE IN CANCER THERAPUTICS The Wistar Institute CUNNINGCHEN, KATHLEEN MARY 1646 §102§103§112DP Final Rejection — Pending Jul 30, 2021
17426201 METHOD FOR DETECTING A SPECIFIC SPLICE EVENT OF A GENE OF INTEREST Klinikum Rechts Der Isar Der Technischen Universität München PERSONS, JENNA L 1637 §112 Final Rejection 11d overdue Pending Jul 28, 2021
17425384 NOVEL BIOMARKERS AND DIAGNOSTIC PROFILES FOR PROSTATE CANCER UEA Enterprises Limited CLOW, LORI A 1687 §101§103§112 Non-Final OA 66d overdue Pending Jul 23, 2021
17371613 GRAPHITIC CARBON NITRIDE MATERIALS AND METHODS OF MAKING AND USE THEREOF New York University ALEJANDRO, RAYMOND 1752 §103 Final Rejection 28d Pending Jul 09, 2021
17317057 DETECTION OF AUTOREACTIVE FECAL IMMUNOGLOBULIN A (IGA) FOR DIAGNOSIS OF LUPUS Musc Foundation For Research Development BALLARD, KIMBERLY 1675 §103 Final Rejection 34d Pending May 11, 2021
17290797 METHODS AND COMPOSITIONS FOR TREATING HEPATOCELLULAR CARCINOMA USING ANTISENSE Thomas Jefferson University VAN DRUFF, SYDNEY 1643 §103DP Final Rejection 6d Pending May 03, 2021
17289882 Quantitative Algorithm for Endometriosis Yale University LIU, GUOZHEN 1686 §101§103§112Other Final Rejection 13d Pending Apr 29, 2021
17283315 Selective Binding and Aggregation of Human Keratin in the Skin Barrier Using Human Filaggrin Subdomains SD67 and SD150 Yale University DABKOWSKI, ERINNE R 1654 §112 Final Rejection 57d Pending Apr 07, 2021
17268635 PHARMACEUTICAL COMPOSITION FOR TREATING CARTILAGE DAMAGE, COMPRISING NASAL SEPTUM CHONDROCYTES The Catholic University Of Korea Industry-Academic Cooperation Foundation RIGA, MICHAEL ANGELO 1634 §103§112 Final Rejection — Pending Feb 16, 2021
17263595 POLYSIALIC ACID AND DERIVATIVES THEREOF, PHARMACEUTICAL COMPOSITION AND METHOD OF PRODUCING POLYSIALIC ACID DEUTSCHES ZENTRUM FÜR NEURODEGENERATIVE ERKRANKUNGEN E.V. CREWS, JARET JAMES 1691 §112 Final Rejection — Pending Jan 27, 2021
17111158 DIAGNOSIS AND TREATMENT FOR RESPIRATORY TRACT DISEASES The United States Government AS Represented By The Department Of Veterans Af PERREIRA, MELISSA JEAN 1618 DP Final Rejection 50d Pending Dec 03, 2020
17046829 CLASSIFICATION AND PROGNOSIS OF PROSTATE CANCER UEA Enterprises Limited LEVERETT, MARY CHANG 1687 §101 Final Rejection — Pending Oct 12, 2020
16963450 DOWNSTREAM DELIVERY OF AGENTS IN SOLID ORGAN TRANSPLANTATION The Regents of the University of California VARGAS, ANNA ELIZABETH 3783 §103 Non-Final OA — Pending Jul 20, 2020
16487458 METHOD FOR ISOLATING HUMAN BRAIN TISSUE-DERIVED NEURAL STEM CELL AT HIGH EFFICIENCY Medinno Inc. GONZALES, JOSEPHINE MARIA 1631 §103§112 Final Rejection — Pending Aug 21, 2019
16484953 Methods and Compositions for Treating Neurodegeneration and Fibrosis Temple University-Of The Commonwealth System Of Higher Education CHERNYSHEV, OLGA N 1675 §112 Final Rejection — Pending Aug 09, 2019
16347861 DNA ANTIBODY CONSTRUCTS FOR USE AGAINST LYME DISEASE The Wistar Institute ZEMAN, ROBERT A 1645 §112 Non-Final OA 10d overdue Pending May 07, 2019
15548197 INTEGRATED PAINLESS BONE MARROW BIOPSY DEVICE Yale University CATINA, MICHAEL ANTHONY 3791 §103 Final Rejection 30d Pending Aug 02, 2017

Managing Riverside Law LLP's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month